Lactated Ringer's Injection is an intravenous solution used to provide water, electrolytes, and alkalinization. It can induce diuresis and its lactate ions are metabolized to produce a metabolic alkalosis. It is administered via IV at a maximum daily dose of 40mL/kg and 5mL/kg/hr. It is indicated for replenishing fluids and electrolytes or as an alkalinizing agent. Precautions are needed when given with drugs affecting sodium, fluid levels, or pH-dependent elimination. Nurses must monitor for signs of dehydration, fluid overload, and electrolyte abnormalities.
Lactated Ringer's Injection is an intravenous solution used to provide water, electrolytes, and alkalinization. It can induce diuresis and its lactate ions are metabolized to produce a metabolic alkalosis. It is administered via IV at a maximum daily dose of 40mL/kg and 5mL/kg/hr. It is indicated for replenishing fluids and electrolytes or as an alkalinizing agent. Precautions are needed when given with drugs affecting sodium, fluid levels, or pH-dependent elimination. Nurses must monitor for signs of dehydration, fluid overload, and electrolyte abnormalities.
Lactated Ringer's Injection is an intravenous solution used to provide water, electrolytes, and alkalinization. It can induce diuresis and its lactate ions are metabolized to produce a metabolic alkalosis. It is administered via IV at a maximum daily dose of 40mL/kg and 5mL/kg/hr. It is indicated for replenishing fluids and electrolytes or as an alkalinizing agent. Precautions are needed when given with drugs affecting sodium, fluid levels, or pH-dependent elimination. Nurses must monitor for signs of dehydration, fluid overload, and electrolyte abnormalities.
Lactated Ringer's Injection is an intravenous solution used to provide water, electrolytes, and alkalinization. It can induce diuresis and its lactate ions are metabolized to produce a metabolic alkalosis. It is administered via IV at a maximum daily dose of 40mL/kg and 5mL/kg/hr. It is indicated for replenishing fluids and electrolytes or as an alkalinizing agent. Precautions are needed when given with drugs affecting sodium, fluid levels, or pH-dependent elimination. Nurses must monitor for signs of dehydration, fluid overload, and electrolyte abnormalities.
CLASSIFICATION: Intravenous nutritional products MODE OF ACTION: Lactated Ringer’s Injection, USP has value as a source of water and electrolytes. It is capable of inducing diuresis depending on the clinical condition of the patient. Lactated Ringer’s Injection, USP produces a metabolic alkalinizing effect. Lactate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cations.
DOSE AND ROUTE:
Adults and adolescence Maximum daily dose Up to 40mLper kg body weight (BW)/day, corresponding to 5.24 mmol sodiumper kg BW per day and max. .22 mmol potassiumper kg BW/day. Maximum infusion rate The infusion rate should be adjusted according to the patient’s clinical condition. The infusion rate should normally not exceed the following values: 5m/kg BW/hr INDICATION: Lactated Ringer’s Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent. CONTRAINDICATION: • Newborns (≤28 days of age) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream. • Patients older than 28 days, including adults, administered ceftriaxone simultaneously through the same infusion line (e.g., via a Y-connector). If the same infusion line is used for sequential administration, the line must be thoroughly flushed between infusions with a compatible fluid. • Patients with known hypersensitivity to sodium lactate
SIDE EFFECTS: Abdominal or stomach pain, bloating or swelling of the face,
arms, hands, lower legs, or feet, blurred vision, body aches or pain, chills, confusion, convulsions, cough, decreased urine, difficulty with breathing
ADVERSE EFFECTS: dizziness, dizziness, faintness, or lightheadedness when
getting up suddenly from a lying or sitting position, dry mouth, ear congestion, fever, headache, increased thirst, irregular heartbeat, loss of appetite, loss of voice and muscle pain or cramps
DRUG INTERACTIONS: Ceftriaxone
Caution is advised when administering Lactated Ringer's Injection to patients
treated with drugs that may increase the risk of sodium and fluid retention, such as corticosteroids.
Caution is advised when administering Lactated Ringer's Injection to patients
treated with drugs for which renal elimination is pH dependent. Due to the alkalinizing action of lactate (formation of bicarbonate), Lactated Ringer's Injection may interfere with the elimination of such drugs.
Renal clearance of acidic drugs such as salicylates and barbiturates may
be increased. Renal clearance of alkaline drugs, such as sympathomimetics (e.g., ephedrine, pseudoephedrine) and dextroamphetamine (dexamphetamine) sulfate, may be decreased.
Renal clearance of lithium may also be increased. Caution is advised when
administering Lactated Ringer's Injection to patients treated with lithium.
Because of its potassium content, Lactated Ringer's Injection should be
administered with caution in patients treated with agents or products that can cause hyperkalemia or increase risk of hyperkalemia, such as potassium sparing diuretics (amiloride, spironolactone, triamterene), with ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants tacrolimus and cyclosporine.
Caution is advised when administering Lactated Ringer's Injection to patients
treated with thiazide diuretics or vitamin D, as these can increase the risk of hypercalcemia. NURSING RESPONSIBILITIES: Document baseline vital signs, edema, lung sounds, and heart sounds, and continue monitoring during and after the infusion. Monitor for continued signs of hypovolemia, including urine output < 0.5 mL/kg/hour, poor skin turgor, tachycardia, weak pulse, and hypotension. Monitor for signs of hypervolemia such as hypertension, bounding pulse, pulmonary crackles, dyspnea, shortness of breath, peripheral edema, jugular vein distension (JVD) and extra heart sounds such as S3 Administer only in high acuity areas. For short-term use to correct critical electrolyte abnormalities. Monitor electrolytes and assess for hypervolemia. ... Avoid in patients with cardiac or renal conditions who are dehydrated, and in patients with diabetic ketoacidosis.
DRUG INTERACTION NI SYA SA SALBUTAMOL
Tell your doctor of all prescription and nonprescription medications you use, including: beta-blockers (e.g., propranolol, timolol), all asthma medications, ephedrine, epinephrine, pseudoephedrine, antidepressants, MAO inhibitors (e.g., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine), diuretics (e.g., hydrochlorothiazide). It is important to read the labels carefully on all over-the-counter medications, especially those used for colds, allergies, asthma or diets as they may contain ingredients mentioned above. Do not start or stop any medicine without doctor or pharmacist approval.